Having supplied more than 90 per cent of India’s vaccine doses, Serum Institute of India (SII) played a pivotal role in ensuring the country reached the milestone of 1 billion jabs. SII CEO Adar Poonawalla tells Sohini Das that India now has 3-4 weeks’ buffer stock, and exports will pick up in January. Edited excerpts:
You are supplying over 200 million doses a month. How did you plan the scale up?
We had taken a lot of risk and planned our execution in early 2020. The fruits of that labour are finally showing. All the other vaccine manufacturers will also